as 12-23-2024 11:30am EST
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Founded: | 1984 | Country: | United States |
Employees: | N/A | City: | SAN DIEGO |
Market Cap: | 5.0M | IPO Year: | N/A |
Target Price: | $7.00 | AVG Volume (30 days): | 6.6M |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.70 | EPS Growth: | N/A |
52 Week Low/High: | $0.24 - $2.35 | Next Earning Date: | 02-12-2025 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AEMD Breaking Stock News: Dive into AEMD Ticker-Specific Updates for Smart Investing
PR Newswire
3 days ago
GlobeNewswire
20 days ago
Zacks Small Cap Research
a month ago
Newsfile
a month ago
GuruFocus.com
a month ago
PR Newswire
a month ago
Newsfile
a month ago
Medical Device Network
a month ago
The information presented on this page, "AEMD Aethlon Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.